nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Blood glucose increased—Progesterone—uterine cancer	0.0405	0.0405	CcSEcCtD
Pasireotide—Cholelithiasis—Medroxyprogesterone Acetate—uterine cancer	0.0302	0.0302	CcSEcCtD
Pasireotide—Electrocardiogram QT prolonged—Medroxyprogesterone Acetate—uterine cancer	0.0293	0.0293	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Progesterone—uterine cancer	0.0252	0.0252	CcSEcCtD
Pasireotide—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.0187	0.0187	CcSEcCtD
Pasireotide—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.0157	0.0157	CcSEcCtD
Pasireotide—Pain in extremity—Progesterone—uterine cancer	0.015	0.015	CcSEcCtD
Pasireotide—Prothrombin level increased—Epirubicin—uterine cancer	0.0145	0.0145	CcSEcCtD
Pasireotide—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.014	0.014	CcSEcCtD
Pasireotide—Pain in extremity—Medroxyprogesterone Acetate—uterine cancer	0.0136	0.0136	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.0135	0.0135	CcSEcCtD
Pasireotide—Nasopharyngitis—Progesterone—uterine cancer	0.0135	0.0135	CcSEcCtD
Pasireotide—Prothrombin level increased—Doxorubicin—uterine cancer	0.0134	0.0134	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Progesterone—uterine cancer	0.0133	0.0133	CcSEcCtD
Pasireotide—Abdominal distension—Progesterone—uterine cancer	0.0131	0.0131	CcSEcCtD
Pasireotide—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.0125	0.0125	CcSEcCtD
Pasireotide—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.0124	0.0124	CcSEcCtD
Pasireotide—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.0122	0.0122	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.012	0.012	CcSEcCtD
Pasireotide—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0119	CcSEcCtD
Pasireotide—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.0118	0.0118	CcSEcCtD
Pasireotide—Hyperglycaemia—Progesterone—uterine cancer	0.0117	0.0117	CcSEcCtD
Pasireotide—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.0106	0.0106	CcSEcCtD
Pasireotide—Oedema peripheral—Progesterone—uterine cancer	0.0103	0.0103	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00957	0.00957	CcSEcCtD
Pasireotide—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00929	0.00929	CcSEcCtD
Pasireotide—Alopecia—Progesterone—uterine cancer	0.0092	0.0092	CcSEcCtD
Pasireotide—Back pain—Progesterone—uterine cancer	0.00876	0.00876	CcSEcCtD
Pasireotide—Anaemia—Progesterone—uterine cancer	0.00837	0.00837	CcSEcCtD
Pasireotide—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00833	0.00833	CcSEcCtD
Pasireotide—Vertigo—Progesterone—uterine cancer	0.00814	0.00814	CcSEcCtD
Pasireotide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00794	0.00794	CcSEcCtD
Pasireotide—Hypertension—Progesterone—uterine cancer	0.00782	0.00782	CcSEcCtD
Pasireotide—Arthralgia—Progesterone—uterine cancer	0.00771	0.00771	CcSEcCtD
Pasireotide—Myalgia—Progesterone—uterine cancer	0.00771	0.00771	CcSEcCtD
Pasireotide—Anxiety—Progesterone—uterine cancer	0.00769	0.00769	CcSEcCtD
Pasireotide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00759	0.00759	CcSEcCtD
Pasireotide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00738	0.00738	CcSEcCtD
Pasireotide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00699	0.00699	CcSEcCtD
Pasireotide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00699	0.00699	CcSEcCtD
Pasireotide—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00696	0.00696	CcSEcCtD
Pasireotide—Hypotension—Progesterone—uterine cancer	0.00691	0.00691	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00679	0.00679	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00674	0.00674	CcSEcCtD
Pasireotide—Insomnia—Progesterone—uterine cancer	0.00669	0.00669	CcSEcCtD
Pasireotide—Alopecia—Dactinomycin—uterine cancer	0.0065	0.0065	CcSEcCtD
Pasireotide—Decreased appetite—Progesterone—uterine cancer	0.00643	0.00643	CcSEcCtD
Pasireotide—Fatigue—Progesterone—uterine cancer	0.00637	0.00637	CcSEcCtD
Pasireotide—Constipation—Progesterone—uterine cancer	0.00632	0.00632	CcSEcCtD
Pasireotide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00626	0.00626	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0061	0.0061	CcSEcCtD
Pasireotide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00606	0.00606	CcSEcCtD
Pasireotide—Gastrointestinal pain—Progesterone—uterine cancer	0.00605	0.00605	CcSEcCtD
Pasireotide—Anaemia—Dactinomycin—uterine cancer	0.00592	0.00592	CcSEcCtD
Pasireotide—Injection site reaction—Epirubicin—uterine cancer	0.00591	0.00591	CcSEcCtD
Pasireotide—Abdominal pain—Progesterone—uterine cancer	0.00584	0.00584	CcSEcCtD
Pasireotide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00582	0.00582	CcSEcCtD
Pasireotide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00578	0.00578	CcSEcCtD
Pasireotide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00573	0.00573	CcSEcCtD
Pasireotide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00548	0.00548	CcSEcCtD
Pasireotide—Injection site reaction—Doxorubicin—uterine cancer	0.00547	0.00547	CcSEcCtD
Pasireotide—Myalgia—Dactinomycin—uterine cancer	0.00545	0.00545	CcSEcCtD
Pasireotide—Asthenia—Progesterone—uterine cancer	0.0053	0.0053	CcSEcCtD
Pasireotide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.0053	0.0053	CcSEcCtD
Pasireotide—Pruritus—Progesterone—uterine cancer	0.00523	0.00523	CcSEcCtD
Pasireotide—Diarrhoea—Progesterone—uterine cancer	0.00506	0.00506	CcSEcCtD
Pasireotide—Diabetes mellitus—Epirubicin—uterine cancer	0.00496	0.00496	CcSEcCtD
Pasireotide—Dizziness—Progesterone—uterine cancer	0.00489	0.00489	CcSEcCtD
Pasireotide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00481	0.00481	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00476	0.00476	CcSEcCtD
Pasireotide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00474	0.00474	CcSEcCtD
Pasireotide—Alopecia—Etoposide—uterine cancer	0.0047	0.0047	CcSEcCtD
Pasireotide—Vomiting—Progesterone—uterine cancer	0.0047	0.0047	CcSEcCtD
Pasireotide—Headache—Progesterone—uterine cancer	0.00463	0.00463	CcSEcCtD
Pasireotide—Diabetes mellitus—Doxorubicin—uterine cancer	0.00459	0.00459	CcSEcCtD
Pasireotide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00458	0.00458	CcSEcCtD
Pasireotide—Decreased appetite—Dactinomycin—uterine cancer	0.00454	0.00454	CcSEcCtD
Pasireotide—Fatigue—Dactinomycin—uterine cancer	0.00451	0.00451	CcSEcCtD
Pasireotide—Back pain—Etoposide—uterine cancer	0.00448	0.00448	CcSEcCtD
Pasireotide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00443	0.00443	CcSEcCtD
Pasireotide—Hypoglycaemia—Epirubicin—uterine cancer	0.00442	0.00442	CcSEcCtD
Pasireotide—Nausea—Progesterone—uterine cancer	0.00439	0.00439	CcSEcCtD
Pasireotide—Pain in extremity—Epirubicin—uterine cancer	0.00431	0.00431	CcSEcCtD
Pasireotide—Anaemia—Etoposide—uterine cancer	0.00428	0.00428	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00427	0.00427	CcSEcCtD
Pasireotide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00426	0.00426	CcSEcCtD
Pasireotide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0042	0.0042	CcSEcCtD
Pasireotide—Vertigo—Etoposide—uterine cancer	0.00416	0.00416	CcSEcCtD
Pasireotide—Abdominal pain—Dactinomycin—uterine cancer	0.00413	0.00413	CcSEcCtD
Pasireotide—Hypoglycaemia—Doxorubicin—uterine cancer	0.00409	0.00409	CcSEcCtD
Pasireotide—Hypertension—Etoposide—uterine cancer	0.004	0.004	CcSEcCtD
Pasireotide—Pain in extremity—Doxorubicin—uterine cancer	0.00399	0.00399	CcSEcCtD
Pasireotide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00398	0.00398	CcSEcCtD
Pasireotide—Dry skin—Epirubicin—uterine cancer	0.00395	0.00395	CcSEcCtD
Pasireotide—Abdominal pain upper—Epirubicin—uterine cancer	0.00394	0.00394	CcSEcCtD
Pasireotide—Hypokalaemia—Epirubicin—uterine cancer	0.00393	0.00393	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00388	0.00388	CcSEcCtD
Pasireotide—Nasopharyngitis—Epirubicin—uterine cancer	0.00386	0.00386	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.0038	0.0038	CcSEcCtD
Pasireotide—Abdominal distension—Epirubicin—uterine cancer	0.00375	0.00375	CcSEcCtD
Pasireotide—Asthenia—Dactinomycin—uterine cancer	0.00375	0.00375	CcSEcCtD
Pasireotide—Influenza—Epirubicin—uterine cancer	0.00373	0.00373	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—uterine cancer	0.00366	0.00366	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—uterine cancer	0.00365	0.00365	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—uterine cancer	0.00363	0.00363	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00359	0.00359	CcSEcCtD
Pasireotide—Diarrhoea—Dactinomycin—uterine cancer	0.00358	0.00358	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—uterine cancer	0.00357	0.00357	CcSEcCtD
Pasireotide—Hypotension—Etoposide—uterine cancer	0.00353	0.00353	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00352	0.00352	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—uterine cancer	0.00347	0.00347	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—uterine cancer	0.00345	0.00345	CcSEcCtD
Pasireotide—Hyperglycaemia—Epirubicin—uterine cancer	0.00336	0.00336	CcSEcCtD
Pasireotide—Vomiting—Dactinomycin—uterine cancer	0.00332	0.00332	CcSEcCtD
Pasireotide—Decreased appetite—Etoposide—uterine cancer	0.00329	0.00329	CcSEcCtD
Pasireotide—Fatigue—Etoposide—uterine cancer	0.00326	0.00326	CcSEcCtD
Pasireotide—Constipation—Etoposide—uterine cancer	0.00323	0.00323	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—uterine cancer	0.00311	0.00311	CcSEcCtD
Pasireotide—Nausea—Dactinomycin—uterine cancer	0.0031	0.0031	CcSEcCtD
Pasireotide—Gastrointestinal pain—Etoposide—uterine cancer	0.00309	0.00309	CcSEcCtD
Pasireotide—Abdominal pain—Etoposide—uterine cancer	0.00299	0.00299	CcSEcCtD
Pasireotide—Oedema peripheral—Epirubicin—uterine cancer	0.00294	0.00294	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—uterine cancer	0.00272	0.00272	CcSEcCtD
Pasireotide—Asthenia—Etoposide—uterine cancer	0.00271	0.00271	CcSEcCtD
Pasireotide—Pruritus—Etoposide—uterine cancer	0.00268	0.00268	CcSEcCtD
Pasireotide—Alopecia—Epirubicin—uterine cancer	0.00264	0.00264	CcSEcCtD
Pasireotide—Diarrhoea—Etoposide—uterine cancer	0.00259	0.00259	CcSEcCtD
Pasireotide—Back pain—Epirubicin—uterine cancer	0.00251	0.00251	CcSEcCtD
Pasireotide—Dizziness—Etoposide—uterine cancer	0.0025	0.0025	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—uterine cancer	0.00244	0.00244	CcSEcCtD
Pasireotide—Vomiting—Etoposide—uterine cancer	0.0024	0.0024	CcSEcCtD
Pasireotide—Anaemia—Epirubicin—uterine cancer	0.0024	0.0024	CcSEcCtD
Pasireotide—Headache—Etoposide—uterine cancer	0.00237	0.00237	CcSEcCtD
Pasireotide—Vertigo—Epirubicin—uterine cancer	0.00233	0.00233	CcSEcCtD
Pasireotide—Back pain—Doxorubicin—uterine cancer	0.00232	0.00232	CcSEcCtD
Pasireotide—Nausea—Etoposide—uterine cancer	0.00225	0.00225	CcSEcCtD
Pasireotide—Hypertension—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Pasireotide—Anaemia—Doxorubicin—uterine cancer	0.00222	0.00222	CcSEcCtD
Pasireotide—Arthralgia—Epirubicin—uterine cancer	0.00221	0.00221	CcSEcCtD
Pasireotide—Myalgia—Epirubicin—uterine cancer	0.00221	0.00221	CcSEcCtD
Pasireotide—Anxiety—Epirubicin—uterine cancer	0.0022	0.0022	CcSEcCtD
Pasireotide—Vertigo—Doxorubicin—uterine cancer	0.00216	0.00216	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—uterine cancer	0.00208	0.00208	CcSEcCtD
Pasireotide—Arthralgia—Doxorubicin—uterine cancer	0.00205	0.00205	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—uterine cancer	0.00205	0.00205	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Pasireotide—Hypotension—Epirubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00193	0.00193	CcSEcCtD
Pasireotide—Insomnia—Epirubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Pasireotide—Decreased appetite—Epirubicin—uterine cancer	0.00184	0.00184	CcSEcCtD
Pasireotide—Hypotension—Doxorubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Pasireotide—Fatigue—Epirubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Pasireotide—Constipation—Epirubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Pasireotide—Insomnia—Doxorubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Pasireotide—Gastrointestinal pain—Epirubicin—uterine cancer	0.00173	0.00173	CcSEcCtD
Pasireotide—Decreased appetite—Doxorubicin—uterine cancer	0.00171	0.00171	CcSEcCtD
Pasireotide—Fatigue—Doxorubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Pasireotide—Constipation—Doxorubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Pasireotide—Abdominal pain—Epirubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Pasireotide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.0016	0.0016	CcSEcCtD
Pasireotide—Abdominal pain—Doxorubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Pasireotide—Asthenia—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Pasireotide—Pruritus—Epirubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Pasireotide—Diarrhoea—Epirubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Pasireotide—Asthenia—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Pasireotide—Dizziness—Epirubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Pasireotide—Pruritus—Doxorubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Pasireotide—Vomiting—Epirubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Pasireotide—Diarrhoea—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Pasireotide—Headache—Epirubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Pasireotide—Dizziness—Doxorubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Pasireotide—Nausea—Epirubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Pasireotide—Vomiting—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Pasireotide—Headache—Doxorubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Pasireotide—Nausea—Doxorubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
